Economic evaluation and catheter-related bloodstream infections

被引:43
作者
Halton, Kate
Graves, Nicholas
机构
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Ctr Hlth Related Infect Surveillance & Prevent, Brisbane, Qld, Australia
关键词
D O I
10.3201/eid1306.070048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Catheter-related bloodstream infections are a serious problem. Many interventions reduce risk, and some have been evaluated in cost-effectiveness studies. We review the usefulness and quality of these economic studies. Evidence is incomplete, and data required to inform a coherent policy are missing. The cost-effectiveness studies are characterized by a lack of transparency, short time-horizons, and narrow economic perspectives. Data quality is low for some important model parameters. Authors of future economic evaluations should aim to model the complete policy and not just single interventions. They should be rigorous in developing the structure of the economic model, include all relevant economic outcomes, use a systematic approach for selecting data sources for model parameters, and propagate the effect of uncertainty in model parameters on conclusions. This will inform future data collection and improve our understanding of the economics of preventing these infections.
引用
收藏
页码:815 / 823
页数:9
相关论文
共 39 条
[1]   A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence [J].
Ades, AE .
STATISTICS IN MEDICINE, 2003, 22 (19) :2995-3016
[2]  
[Anonymous], 2003, The Cochrane Reviewers Handbook 4.2.0 [updated March 2003]
[3]  
[Anonymous], [No title captured]
[4]  
[Anonymous], 2001, EC EVALUATION HLTH C
[5]   Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections [J].
Blot, SI ;
Depuydt, P ;
Annemans, L ;
Benoit, D ;
Hoste, E ;
de Waele, JJ ;
Decruyenaere, J ;
Vogelaers, D ;
Colardyn, F ;
Vandewoude, KH .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (11) :1591-1598
[6]   National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].
Cardo, D ;
Horan, T ;
Andrus, M ;
Dembinski, M ;
Edwards, J ;
Peavy, G ;
Tolson, J ;
Wagner, D .
AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485
[7]   Vascular catheter site care: The clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine [J].
Chaiyakunapruk, N ;
Veenstra, DL ;
Lipsky, BA ;
Sullivan, SD ;
Saint, S .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :764-771
[8]   A rational framework for decision making by the National Institute for Clinical Excellence (NICE) [J].
Claxton, K ;
Sculpher, M ;
Drummond, M .
LANCET, 2002, 360 (9334) :711-715
[9]  
Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187
[10]  
Coyle D, 2002, Evidence-based health economics: from effectiveness to efficiency in systematic review, P55